1. Bekeredjian R, Grayburn PA. Valvular heart disease: aortic regurgitation. Circulation. 2005; 112(1): 125 - 34.

2. Maurer G. Aortic regurgitation. Heart (British Cardiac Society). 2006; 92(7): 994 - 1000.

3. Weiss RM, Miller JD, Heistad DD. Fibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse models. Circulation research. 2013; 113(2): 209 - 22.

4. Esmaeilzadeh M, Alimi H, Maleki M, Hosseini S. Aortic valve injury following blunt chest trauma. Research in cardiovascular medicine. 2014; 3(3): e17319.

5. Хубулава Г.Г., Марченко С.П., Старчик Д.А., Суворов В.В., Кривощеков Е.В., Шихвердиев Н.Н., et al. Геометрические и морфологические характеристики корня аорты в норме и при недостаточности аортального клапана. Хирургия. Журнал им. Н.И. Пирогова. 2018(5): 4 - 12.

6. Lancellotti P, Tribouilloy C, Hagendorff A, Moura L, Popescu BA, Agricola E, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). European journal of echocardiography: the journal of the Working Group on Echocardiography of the European Society of Cardiology. 2010; 11(3): 223 - 44.

7. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014; 129(23): 2440 - 92.

8. Chaliki HP, Mohty D, Avierinos JF, Scott CG, Schaff HV, Tajik AJ, et al. Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation. 2002; 106(21): 2687 - 93.

9. Sambola A, Tornos P, Ferreira-Gonzalez I, Evangelista A. Prognostic value of preoperative indexed end-systolic left ventricle diameter in the outcome after surgery in patients with chronic aortic regurgitation. American heart journal. 2008; 155(6): 1114 - 20.

10. Stefano G, Fox K, Schluchter M, Hoit BD. Prevalence of unsuspected and significant mitral and aortic regurgitation. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography. 2008; 21(1): 38 - 42

11. Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: A report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography. 2017; 30(4): 303 - 71.

12. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O'Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2021; 143(5): e72 - e227.

13. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European heart journal. 2021.

14. Goldstein SA, Evangelista A, Abbara S, Arai A, Asch FM, Badano LP, et al. Multimodality imaging of diseases of the thoracic aorta in adults: from the American Society of Echocardiography and the European Association of Cardiovascular Imaging: endorsed by the Society of Cardiovascular Computed Tomography and Society for Cardiovascular Magnetic Resonance. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography. 2015; 28(2): 119 - 82.

15. Doherty JU, Kort S, Mehran R, Schoenhagen P, Soman P. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 appropriate use criteria for multimodality imaging in valvular heart disease: A report of the American College of Cardiology appropriate use criteria task force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. Journal of the American College of Cardiology. 2017; 70(13): 1647 - 72.

16. de Kerchove L, El Khoury G. Anatomy and pathophysiology of the ventriculo-aortic junction: implication in aortic valve repair surgery. Annals of cardiothoracic surgery. 2013; 2(1): 57 - 64.

17. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, 3rd, Fleisher LA, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Journal of the American College of Cardiology. 2017.

18. Attenhofer Jost CH, Turina J, Mayer K, Seifert B, Amann FW, Buechi M, et al. Echocardiography in the evaluation of systolic murmurs of unknown cause. The American journal of medicine. 2000; 108(8): 614 - 20.

19. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. European heart journal. 2017; 38(36): 2739 - 91.

20. Кардиология. Национальное руководство. Краткое издание. Шляхто Е.В., editor. М.: ГЭОТАР-Медиа; 2019. 816 p.

21. Tutar E, Ekici F, Atalay S, Nacar N. The prevalence of bicuspid aortic valve in newborns by echocardiographic screening. American heart journal. 2005; 150(3): 513 - 5.

22. Stout KK, Verrier ED. Acute valvular regurgitation. Circulation. 2009; 119(25): 3232 - 41.

23. Bruckner BA, Reardon MJ. Bicuspid aortic valve and associated aortopathy: surgical considerations. Methodist Debakey Cardiovasc J. 2010; 6(1): 29 - 32.

24. Agozzino L, Falco A, De Luca Tupputi Schinosa L, De Vivo F, Esposito S, Cotrufo M. Surgical pathology of the aortic valve: a morphologic study on 912 surgically excised valves. Giornale italiano di cardiologia. 1992; 22(10): 1169 - 77.

25. Maganti K, Rigolin VH, Sarano ME, Bonow RO. Valvular heart disease: diagnosis and management. Mayo Clinic proceedings. 2010; 85(5): 483 - 500.

26. Sievers HH, Schmidtke C. A classification system for the bicuspid aortic valve from 304 surgical specimens. The Journal of thoracic and cardiovascular surgery. 2007; 133(5): 1226 - 33.

27. Angelini A, Ho SY, Anderson RH, Devine WA, Zuberbuhler JR, Becker AE, et al. The morphology of the normal aortic valve as compared with the aortic valve having two leaflets. The Journal of thoracic and cardiovascular surgery. 1989; 98(3): 362 - 7.

28. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, , et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. European heart journal. 2021; 42(36): 3599 - 726.

29. Graffeo JM, Persaud H. Aortic regurgitation. Journal of the American Academy of PAs. 2017; 30(8): 47 - 8.

30. , , Yilmaz E, Demir T, Ahunbay G. Predictive value of cardiothoracic ratio as a marker of severity of aortic regurgitation and mitral regurgitation. Anadolu kardiyoloji dergisi: AKD = the Anatolian journal of cardiology. 2007; 7(2): 146 - 9.

31. Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. European heart journal cardiovascular Imaging. 2013; 14(7): 611 - 44.

32. Lancellotti P, Rosenhek R, Pibarot P, Iung B, Otto CM, Tornos P, et al. ESC Working Group on Valvular Heart Disease position paper--heart valve clinics: organization, structure, and experiences. European heart journal. 2013; 34(21): 1597 - 606.

33. Magne J, Cosyns B, Popescu BA, Carstensen HG, Dahl J, Desai MY, et al. Distribution and prognostic significance of left ventricular global longitudinal strain in asymptomatic significant aortic stenosis: an individual participant data meta-analysis. JACC Cardiovascular imaging. 2019; 12(1): 84 - 92.

34. Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). European heart journal. 2014; 35(41): 2873 - 926.

35. Borger MA, Fedak PWM, Stephens EH, Gleason TG, Girdauskas E, Ikonomidis JS, et al. The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Full online-only version. The Journal of thoracic and cardiovascular surgery. 2018; 156(2): e41 - e74.

36. Kammerlander AA, Wiesinger M, Duca F, Aschauer S, Binder C, Zotter Tufaro C, et al. Diagnostic and prognostic utility of cardiac magnetic resonance imaging in aortic regurgitation. JACC Cardiovascular imaging. 2019; 12(8 Pt 1): 1474 - 83.

37. Amsallem M, Ou P, Milleron O, Henry-Feugeas MC, Detaint D, Arnoult F, et al. Comparative assessment of ascending aortic aneurysms in Marfan patients using ECG-gated computerized tomographic angiography versus trans-thoracic echocardiography. International journal of cardiology. 2015; 184: 22 - 7.

38. Freeman LA, Young PM, Foley TA, Williamson EE, Bruce CJ, Greason KL. CT and MRI assessment of the aortic root and ascending aorta. AJR American journal of roentgenology. 2013; 200(6): W581 - 92.

39. Azevedo CF, Nigri M, Higuchi ML, Pomerantzeff PM, Spina GS, Sampaio RO, et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. Journal of the American College of Cardiology. 2010; 56(4): 278 - 87.

40. Bing R, Cavalcante JL, Everett RJ, Clavel MA, Newby DE, Dweck MR. Imaging and impact of myocardial fibrosis in aortic stenosis. JACC Cardiovascular imaging. 2019; 12(2): 283 - 96.

41. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European heart journal. 2019; 40(2): 87 - 165.

42. STS Short-term/Operative Risk Calculator Adult Cardiac Surgery Database - All Procedures https://acsdriskcalc.research.sts.org/

43. EuroSCORE is the world's best-known cardiac surgery risk stratification model https://euroscore.org/

44. Barili F, Pacini D, Capo A, Rasovic O, Grossi C, Alamanni F, et al. Does EuroSCORE II perform better than its original versions? A multicentre validation study. European heart journal. 2013; 34(1): 22 - 9.

45. Shahian DM, Jacobs JP, Badhwar V, Kurlansky PA, Furnary AP, Cleveland JC, Jr., et al. The Society of Thoracic Surgeons 2018 adult cardiac surgery risk models: part 1-background, design considerations, and model development. The Annals of thoracic surgery. 2018; 105(5): 1411 - 8.

46. Kundi H, Popma JJ, Reynolds MR, Strom JB, Pinto DS, Valsdottir LR, et al. Frailty and related outcomes in patients undergoing transcatheter valve therapies in a nationwide cohort. European heart journal. 2019; 40(27): 2231 - 9.

47. Hosler QP, Maltagliati AJ, Shi SM, Afilalo J, Popma JJ, Khabbaz KR, et al. A practical two-stage frailty assessment for older adults undergoing aortic valve replacement. J Am Geriatr Soc. 2019; 67(10): 2031 - 7.

48. Dent E, Martin FC, Bergman H, Woo J, Romero-Ortuno R, Walston JD. Management of frailty: opportunities, challenges, and future directions. Lancet (London, England). 2019; 394(10206): 1376 - 86.

49. Goldfarb M, Lauck S, Webb JG, Asgar AW, Perrault LP, Piazza N, et al. Malnutrition and mortality in frail and non-frail older adults undergoing aortic valve replacement. Circulation. 2018; 138(20): 2202 - 11.

50. Yanagisawa R, Tanaka M, Yashima F, Arai T, Kohno T, Shimizu H, et al. Frequency and consequences of cognitive impairment in patients underwent transcatheter aortic valve implantation. The American journal of cardiology. 2018; 122(5): 844 - 50.

51. Abramowitz Y, Kazuno Y, Chakravarty T, Kawamori H, Maeno Y, Anderson D, et al. Concomitant mitral annular calcification and severe aortic stenosis: prevalence, characteristics and outcome following transcatheter aortic valve replacement. European heart journal. 2017; 38(16): 1194 - 203.

52. Abramowitz Y, Jilaihawi H, Chakravarty T, Mack MJ, Makkar RR. Porcelain aorta: a comprehensive review. Circulation. 2015; 131(9): 827 - 36.

53. Puri R, Iung B, Cohen DJ, TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation. European heart journal. 2016; 37(28): 2217 - 25.

54. Gunter RL, Kilgo P, Guyton RA, Chen EP, Puskas JD, Cooper WA, et al. Impact of preoperative chronic lung disease on survival after surgical aortic valve replacement. The Annals of thoracic surgery. 2013; 96(4): 1322 - 8.

55. Allende R, Webb JG, Munoz-Garcia AJ, de Jaegere P, Tamburino C, Dager AE, et al. Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients. European heart journal. 2014; 35(38): 2685 - 96.

56. Tirado-Conte G, , , Barbanti M, Lhermusier T, Amat-Santos I, et al. Clinical outcomes and prognosis markers of patients with liver disease undergoing transcatheter aortic valve replacement: a propensity score-matched analysis. Circ Cardiovasc Interv. 2018; 11(3): e005727.

57. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European heart journal. 2016; 37(27): 2129 - 200.

58. Lacro RV, Dietz HC, Sleeper LA, Yetman AT, Bradley TJ, Colan SD, et al. Atenolol versus losartan in children and young adults with Marfan's syndrome. The New England journal of medicine. 2014; 371(22): 2061 - 71.

59. Forteza A, Evangelista A, Sanchez V, Teixido-Tura G, Sanz P, Gutierrez L, et al. Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial. European heart journal. 2016; 37(12): 978 - 85.

60. Nadeau-Routhier C, Marsit O, Beaudoin J. Current Management of Patients with Severe Aortic Regurgitation. Current treatment options in cardiovascular medicine. 2017; 19(2): 9.

61. Yang LT, Michelena HI, Scott CG, Enriquez-Sarano M, Pislaru SV, Schaff HV, et al. Outcomes in chronic hemodynamically significant aortic regurgitation and limitations of current guidelines. Journal of the American College of Cardiology. 2019; 73(14): 1741 - 52

62. Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2009; 119(11): 1541 - 51.

63. Elder DH, Wei L, Szwejkowski BR, Libianto R, Nadir A, Pauriah M, et al. The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study. Journal of the American College of Cardiology. 2011; 58(20): 2084 - 91.

64. Seferovic PM, Ponikowski P, Anker SD, Bauersachs J, Chioncel O, Cleland JGF, et al. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019; 21(10): 1169 - 86.

65. Otto CM. Heartbeat: beta-blockers for aortic regurgitation. Heart (British Cardiac Society). 2016; 102(3): 165 - 7.

66. Groenink M, den Hartog AW, Franken R, Radonic T, de Waard V, Timmermans J, et al. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. European heart journal. 2013; 34(45): 3491 - 500.

67. Mullen M, Jin XY, Child A, Stuart AG, Dodd M, Aragon-Martin JA, et al. Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial. Lancet (London, England). 2019; 394(10216): 2263 - 70.

68. Heneghan C, Ward A, Perera R, Bankhead C, Fuller A, Stevens R, et al. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet (London, England). 2012; 379(9813): 322 - 34.

69. Шпилевой Н.Ю., Вавилов П.А., Белова А.Э. Непосредственные и отдаленные результаты протезирования аортального клапана современными двустворчатыми протезами On-X и МедИнж-2. Российский медицинский журнал. 2011; 17(4): 22 - 7.

70. Вавилов П.А. Искусственный клапан сердца "МедИнж-2": 10-летний опыт клинического применения. Вестник трансплантологии и искусственных органов. 2010; 12(3): 29 - 35.

71. Laffort P, Roudaut R, Roques X, Lafitte S, Deville C, Bonnet J, et al. Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude medical prosthesis: a clinical and transesophageal echocardiographic study. Journal of the American College of Cardiology. 2000; 35(3): 739 - 46.

72. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, , et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European heart journal. 2020; 42(5): 373 - 498.

73. Malik AH, Yandrapalli S, Aronow WS, Panza JA, Cooper HA. Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves. Heart (British Cardiac Society). 2019; 105(18): 1432 - 6.

74. Duan L, Doctor JN, Adams JL, Romley JA, Nguyen LA, An J, et al. Comparison of direct oral anticoagulants versus warfarin in patients with atrial fibrillation and bioprosthetic heart valves. The American journal of cardiology. 2021; 146: 22 - 8.

75. Pasciolla S, Zizza LF, Le T, Wright K. Comparison of the efficacy and safety of direct oral anticoagulants and warfarin after bioprosthetic valve replacements. Clin Drug Investig. 2020; 40(9): 839 - 45.

76. Russo V, Carbone A, Attena E, Rago A, Mazzone C, Proietti R, et al. Clinical benefit of direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and bioprosthetic heart valves. Clin Ther. 2019; 41(12): 2549 - 57.

77. Sousa-Uva M, Head SJ, Milojevic M, Collet JP, Landoni G, Castella M, et al. 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery. European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery. 2018; 53(1): 5 - 33.

78. Raffaele De Caterina R, Agewall S, Andreotti F, Angiolillo DJ, Bhatt DL, Byrne RA, Collet JP, Eikelboom J, Fanaroff AC, Gibson CM, Goette A, Hindricks G, Lip GYH, Potpara T, Thiele H, Lopes RD, Galli M. Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week. Eur Heart J. 2022; 43(37): 3512 - 3527.

79. Hansen ML, , Clausen MT, Fog-Petersen ML, , , et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Archives of internal medicine. 2010; 170(16): 1433 - 41.

80. Tornos P, Sambola A, Permanyer-Miralda G, Evangelista A, Gomez Z, Soler-Soler J. Long-term outcome of surgically treated aortic regurgitation: influence of guideline adherence toward early surgery. Journal of the American College of Cardiology. 2006; 47(5): 1012 - 7.

81. Bhudia SK, McCarthy PM, Kumpati GS, Helou J, Hoercher KJ, Rajeswaran J, et al. Improved outcomes after aortic valve surgery for chronic aortic regurgitation with severe left ventricular dysfunction. Journal of the American College of Cardiology. 2007; 49(13): 1465 - 71.

82. Fiedler AG, Bhambhani V, Laikhter E, Picard MH, Wasfy MM, Tolis G, et al. Aortic valve replacement associated with survival in severe regurgitation and low ejection fraction. Heart (British Cardiac Society). 2018; 104(10): 835 - 40.

83. de Meester C, Gerber BL, Vancraeynest D, Pouleur AC, Noirhomme P, Pasquet A, et al. Do guideline-based indications result in an outcome penalty for patients with severe aortic regurgitation? JACC Cardiovascular imaging. 2019; 12(11 Pt 1): 2126 - 38.

84. Mastrobuoni S, de Kerchove L, Navarra E, Watremez C, Vancraeynest D, Rubay J, et al. Long-term experience with valve-sparing reimplantation technique for the treatment of aortic aneurysm and aortic regurgitation. The Journal of thoracic and cardiovascular surgery. 2019; 158(1): 14 - 23.

85. El Khoury G, de Kerchove L. Principles of aortic valve repair. The Journal of thoracic and cardiovascular surgery. 2013; 145(3 Suppl): S26 - 9.

86. Yacoub MH, Fagan A, Pillai R, Radleysmith R, et al. Results of a new valve conserving operation for treatment of aneurysms or acute dissection of the aortic root. Journal of the American College of Cardiology. 1983; 1: 708, ISSN: 0735-1097

87. David TE, Feindel CM. An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta. J Thorac Cardiovasc Surg. 1992 Apr; 103(4): 617 - 21; discussion 622. PMID: 1532219

88. Sarsam MA, Yacoub M. Remodeling of the aortic valve anulus. J Thorac Cardiovasc Surg. 1993 Mar; 105(3): 435 - 8. PMID: 8445922

89. Fu Y, Guidoin R, De Paulis R, Lin J, Li B, Wang L, et al. The Gelweave Valsalva graft to better reconstruct the anatomy of the aortic root. Journal of long-term effects of medical implants. 2016; 26(2): 97 - 121.

90. Lansac E, Di Centa I, Sleilaty G, Lejeune S, Khelil N, Berrebi A, et al. Long-term results of external aortic ring annuloplasty for aortic valve repair. European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery. 2016; 50(2): 350 - 60.

91. Urbanski PP, Zhan X, Hijazi H, Zacher M, Diegeler A. Valve-sparing aortic root repair without down-sizing of the annulus. The Journal of thoracic and cardiovascular surgery. 2012; 143(2): 294 - 302.

92. Hess PJ Jr, Klodell CT, Beaver TM, Martin TD The Florida Sleeve: a new technique for aortic root remodeling with preservation of the aortic valve and sinuses. Ann. Thorac. Surg. 2005; 80: 2: 748 - 750. doi: 10.1016/j.athoracsur.2004.02.092

93. Чернявский А.М., Альсов С.А., Хван Д.С., Сирота Д.А., Ляшенко М.М. Сравнительная клинико-функциональная оценка клапаносохраняющей операции на корне аорты при реимплантации корня аорты в протез. Кардиология и сердечно-сосудистая хирургия. 2014; 7(6): 54 - 8.

94. Чернявский А.М., Сирота Д.А., Альсов С.А., Хван Д.С., Ляшенко М.М. Качество жизни после экстравальвулярного протезирования восходящего отдела аорты протезом с синусами Вальсальвы. Патология кровообращения и кардиохирургия. 2012; 2: 35 - 8.

95. Arabkhani B, Mookhoek A, Di Centa I, Lansac E, Bekkers JA, De Lind Van Wijngaarden R, et al. Reported outcome after valve-sparing aortic root replacement for aortic root aneurysm: a systematic review and meta-analysis. The Annals of thoracic surgery. 2015; 100(3): 1126 - 31.

96. Lee H, Cho YH, Sung K, Kim WS, Park KH, Jeong DS, et al. Clinical outcomes of root reimplantation and Bentall procedure: propensity score matching analysis. The Annals of thoracic surgery. 2018; 106(2): 539 - 47.

97. Schneider U, Feldner SK, Hofmann C, Schope J, Wagenpfeil S, Giebels C, et al. Two decades of experience with root remodeling and valve repair for bicuspid aortic valves. The Journal of thoracic and cardiovascular surgery. 2017; 153(4): S65 - s71.

98. Mazzitelli D, Pfeiffer S, Rankin JS, Fischlein T, Choi YH, Wahlers T, et al. A regulated trial of bicuspid aortic valve repair supported by geometric ring annuloplasty. The Annals of thoracic surgery. 2015; 99(6): 2010 - 6.

99. Tsai YC, Phan K, Munkholm-Larsen S, Tian DH, La Meir M, Yan TD. Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a meta-analysis. European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery. 2015; 47(5): 847 - 54.

100. Yao X, Gersh BJ, Holmes DR, Jr., Melduni RM, Johnsrud DO, Sangaralingham LR, et al. Association of surgical left atrial appendage occlusion with subsequent stroke and mortality among patients undergoing cardiac surgery. Jama. 2018; 319(20): 2116 - 26.

101. , , Gualis J, , Maiorano P, Castillo L, et al. Beneficial effect of left atrial appendage closure during cardiac surgery: a meta-analysis of 280 585 patients. European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery. 2020; 57(2): 252 - 62.

102. Gillinov AM, Gelijns AC, Parides MK, DeRose JJ, Jr., Moskowitz AJ, Voisine P, et al. Surgical ablation of atrial fibrillation during mitral-valve surgery. The New England journal of medicine. 2015; 372(15): 1399 - 409.

103. Diaz R, Hernandez-Vaquero D, Alvarez-Cabo R, Avanzas P, Silva J, Moris C, et al. Long-term outcomes of mechanical versus biological aortic valve prosthesis: Systematic review and meta-analysis. The Journal of thoracic and cardiovascular surgery. 2019; 158(3): 706 - 14. e18.

104. Goldstone AB, Chiu P, Baiocchi M, Lingala B, Patrick WL, Fischbein MP, et al. Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement. The New England journal of medicine. 2017; 377(19): 1847 - 57.

105. David TE, Ouzounian M, David CM, Lafreniere-Roula M, Manlhiot C. Late results of the Ross procedure. The Journal of thoracic and cardiovascular surgery. 2019; 157(1): 201 - 8.

106. Sardo S, Osawa EA, Finco G, Gomes Galas FRB, de Almeida JP, Cutuli SL, Frassanito C, Landoni G, Hajjar LA. Nitric oxide in cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2018 Dec; 32(6): 2512 - 2519. doi: 10.1053/j.jvca.2018.02.003.

107. Tessler J, Bordoni B. Cardiac Rehabilitation. 2022 May 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan. PMID: 30725881.

108. Приказ Министерства здравоохранения РФ от 31 июля 2020 г. N 778н "О Порядке организации медицинской реабилитации взрослых". Зарегистрировано в Минюсте РФ 25 сентября 2020 г. Регистрационный N 60039 https://www.garant.ru/products/ipo/prime/doc/74581688/.

109. Scottish Intercollegiate Guidelines Network (SIGN). Cardiac rehabilitation: a national clinical guideline, 2002.

110. Ambrosetti M, Abreu A, , Davos CH, Hansen D, Frederix I, et al. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. European Journal of Preventive Cardiology. 2021; 28:460-495. doi: 10.1177/2047487320913379.

111. Butchart EG, Gohlke-Barwolf C, Antunes MJ, Tornos P, De Caterina R, Cormier B, et al. Recommendations for the management of patients after heart valve surgery. Eur Heart J. 2005; 26(22): 2463 - 2471. doi: 10.1093/eurheartj/ehi426.

112. Sibilitz KL, Berg SK, Tang LH, Risom SS, Gluud C, Lindschou J, et al. Exercise-based cardiac rehabilitation for adults after heart valve surgery. Cochrane Database Syst Rev. 2016; 3: CD010876. doi: 10.1002/14651858.CD010876.pub2.

113. Sire S. Physical training and occupational rehabilitation after aortic valve replacement. Eur Heart J. 1987; 8: 1215 - 1220. doi: 10.1093/oxfordjournals.eurheartj.a062195.

114. Ueshima K, Kamata J, Kobayashi N, Saito M, Sato S, Kawazoe K, Hiramori K. Effects of exercise training after open heart surgery on quality of life and exercise tolerance in patients with mitral regurgitation or aortic regurgitation. Jpn Heart J. 2004; 45(5): 789 - 797. doi: 10.1536/jhj.45.789.

115. Savage PD, Rengo JL, Menzies KE, Ades PA. Cardiac Rehabilitation after Heart Valve Surgery: Comparison with Coronary Artery Bypass Grafting Patients. J Cardiopulm Rehabil Prev. 2015; 35(4): 231 - 237. doi: 10.1097/HCR.0000000000000104.

116. Gladkova MA, Kassirsky GI. Topical problems in rehabilitation following valve replacement. Cor Vasa. 1984; 26: 394 - 399.

117. Anderson L, Sharp GA, Norton RJ, Dalal H, Dean SG, Jolly K, et al. Home-based versus centre-based cardiac rehabilitation. Cochrane Database of Systematic Reviews. 2017; 6: CD007130. doi: 10.1002/14651858.CD007130.pub4.

118. Thomas RJ, Beatty AL, Beckie TM, Brewer LC, Brown TM, Forman DE. Home-based cardiac rehabilitation: a scientific statement from the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology. Circulation. 2019; 140: e69 - e89. doi: 10.1161/CIR.0000000000000663.

119. Kraal JJ, Van den Akker-Van Marle ME, Abu-Hanna A, Stut W, Peek N, Kemps HM. Clinical and cost-effectiveness of home-based cardiac rehabilitation compared to conventional, centre-based cardiac rehabilitation: results of the FIT@Home study. Eur J Prev Cardiol. 2017; 24(12): 1260 - 1273. doi: 10.1177/2047487317710803.

120. Федеральный закон от 29.07.2017 г. N 242-ФЗ "О внесении изменений в отдельные законодательные акты Российской Федерации по вопросам применения информационных технологий в сфере охраны здоровья" https://www.garant.ru/products/ipo/prime/doc/71632844/.

121. Kanejima Y, Shimogai T, Kitamura M, Ishihara K, Izawa KP. Effect of Early Mobilization on Physical Function in Patients after Cardiac Surgery: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2020 Sep 28; 17(19): 7091. doi: 10.3390/ijerph17197091. PMID: 32998202; PMCID: PMC7578990.

122. Sahar W, Ajaz N, Haider Z, Jalal A. Effectiveness of Pre-operative Respiratory Muscle Training versus Conventional Treatment for Improving Post operative Pulmonary Health after Coronary Artery Bypass Grafting. Pak J Med Sci. 2020 Sep - Oct; 36(6): 1216 - 1219.

123. Borregaard B, Dahl JS, Riber LPS, Ekholm O, Sibilitz KL, Weiss M, , Berg SK, Effect of early, individualised and intensified follow-up after open heart valve surgery on unplanned cardiac hospital readmissions and all-cause mortality. Int J Cardiol. 2019 Aug 15; 289: 30 - 36. doi: 10.1016/j.ijcard.2019.02.056. Epub 2019 Apr 11. PMID: 31006596.

124. Thomas RJ, Balady G, Banka G, Beckie TM, Chiu J, Gokak S, et al. 2018 ACC/AHA Clinical Performance and Quality Measures for Cardiac Rehabilitation: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2018; 71(16): 1814 - 1837.

125. Иванова Г.Е., Мельникова Е.В., Шмонин А.А., Вербицкая Е.В., Аронов Д.М., Белкин А.А., Беляев А.Ф., Бодрова Р.А., Бубнова М.Г., Буйлова Т.В., Мальцева М.Н., Мишина И.Е., Нестерин К.В., Никифоров В.В., Прокопенко С.В., Сарана А.М., Стаховская Л.В., Суворов А.Ю., Хасанова Д.Р., Цыкунов М.Б. Применение международной классификации функционирования в процессе медицинской реабилитации. Вестник восстановительной медицины. 2018. N 6 (88). С. 2 - 77. eLIBRARY ID: 36486374.

126. STS Short-term/Operative Risk Calculator Adult Cardiac Surgery Database - All Procedures https://acsdriskcalc.research.sts.org/

127. European system for cardiac operative risk evaluation https://www.euroscore.org/

128. Sommaruga M, Angelino E, Porta PD, Abatello M, Baiardo G, Balestroni G, et al. Best practice in psychological activities in cardiovascular prevention and rehabilitation: Position Paper. Monaldi Arch Chest Dis. 2018; 88(2): 966. doi: 10.4081/monaldi.2018.966

129. Visseren FLJ. Mach F, Smulders YM, Carballo D, Koskinas KC, , et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34): 3227 - 3337. doi: 10.1093/eurheartj/ehab484.

130. Ambrosetti M, Abreu A, Cornelissen V, Dominique H, Iliou MC, Hareld K, et al. Delphi consensus recommendations on how to provide cardiovascular rehabilitation in the COVID-19 era. Eur J Prev Cardiol. 2021; 28(5): 541 - 557. doi: 10.1093/eurjpc/zwaa080. PMID: 33624042; PMCID: PMC7717287

131. Mezzani A, Hamm LF, Jones AM, McBride PE, Moholdt T, Stone JA, et al. Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: A joint position statement of the European association for cardiovascular prevention and rehabilitation, the American association of cardiovascular and pulmonary rehabilitation and the Canadian association of cardiac rehabilitation. Eur J Prev Cardiol. 2013; 20: 442 - 467. doi: 10.1177/2047487312460484. PMID: 23104970.

132. Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, et al. Exercise Standards for Testing and Training A Scientific Statement From the American Heart Association. Circulation. 2013; 128: 873 - 934. doi: 10.1161/CIR.0b013e31829b5b44.

133. Opasich C, De Feo S, Pinna GD, Furgi G, Pedretti R, Scrutinio D, Tramarin R. Distance walked in the 6-minute test soon after cardiac surgery: toward an efficient use in the individual patient. Chest. 2004; 126(6): 1796 - 1801. doi: 10.1378/chest.126.6.1796

134. Oyama J, Kudo Y, Maeda T, Node K, Makino N. Hyperthermia by bathing in a hot spring improves cardiovascular functions and reduces the production of inflammatory cytokines in patients with chronic heart failure. Heart Vessels. 2013 Mar; 28(2): 173 - 8. doi: 10.1007/s00380-011-0220-7. Epub 2012 Jan 11. PMID: 22231540.

135. The British Association for Cardiovascular Prevention and Rehabilitation. The BACPR Standards and Core Components for Cardiovascular Disease Prevention and Rehabilitation 2012 (2nd edition). The British Cardiovascular Society 2012.

136. Ambrosetti M, Abreu A, , Davos CH, Hansen D, Frederix I, Iliou MC, Pedretti RFE, Schmid JP, Vigorito C, Voller H, Wilhelm M, Piepoli MF, Bjarnason-Wehrens B, Berger T, Cohen-Solal A, Cornelissen V, Dendale P, Doehner W, Gaita D, Gevaert AB, Kemps H, Kraenkel N, Laukkanen J, Mendes M, Niebauer J, Simonenko M, Zwisler AO. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2021 May 14; 28(5): 460 - 495. doi: 10.1177/2047487320913379. PMID: 33611446.

137. Abraham LN, Sibilitz KL, Berg SK, Tang LH, Risom SS, Lindschou J, Taylor RS, Borregaard B, Zwisler AD. Exercise-based cardiac rehabilitation for adults after heart valve surgery. Cochrane Database Syst Rev. 2021 May 7; 5(5): CD010876. doi: 10.1002/14651858.

138. Sibilitz KL, Berg SK, Tang LH, Risom SS, Gluud C, Lindschou J, Kober L, Hassager C, Taylor RS, Zwisler AD. Exercise-based cardiac rehabilitation for adults after heart valve surgery. Cochrane Database Syst Rev. 2016 Mar 21; 3: CD010876. doi: 10.1002/1465185

139. Князева Т.А., Бадтиева В.А. Физиобальнеотерапия сердечно-сосудистых заболеваний. Практическое руководство. М. Медпресс-информ, 2008. - 272 с.

140. Приказ Министерства здравоохранения РФ от 28 сентября 2020 г. N 1029н "Об утверждении перечней медицинских показаний и противопоказаний для санаторно-курортного лечения".

141. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). European heart journal. 2015; 36(44): 3075 - 128.

142. Borer JS, Sharma A. Drug therapy for heart valve diseases. Circulation. 2015; 132(11): 1038 - 45.

143. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). European heart journal. 2016; 37(29): 2315 - 81.

144. Clavel MA, Tribouilloy C, Vanoverschelde JL, Pizarro R, Suri RM, Szymanski C, et al. Association of B-type natriuretic peptide with survival in patients with degenerative mitral regurgitation. Journal of the American College of Cardiology. 2016; 68(12): 1297 - 307.

145. Lindman BR, Clavel MA, Mathieu P, Iung B, Lancellotti P, Otto CM, et al. Calcific aortic stenosis. Nat Rev Dis Primers. 2016; 2: 16006.

146. Lindman BR, Clavel MA, Abu-Alhayja'a R, , Dagenais F, Novak E, et al. Multimarker approach to identify patients with higher mortality and rehospitalization rate after surgical aortic valve replacement for aortic stenosis. JACC Cardiovasc Interv. 2018; 11(21): 2172 - 81.

147. Prihadi EA, Vollema EM, Ng ACT, Ajmone Marsan N, Bax JJ, Delgado V. Determinants and prognostic implications of left ventricular mechanical dispersion in aortic stenosis. European heart journal cardiovascular Imaging. 2019; 20(7): 740 - 8.

148. le Polain de Waroux JB, Pouleur AC, Goffinet C, Vancraeynest D, Van Dyck M, Robert A, et al. Functional anatomy of aortic regurgitation: accuracy, prediction of surgical repairability, and outcome implications of transesophageal echocardiography. Circulation. 2007; 116(11 Suppl): I264 - 9.

149. Maron BJ, Zipes DP, Kovacs RJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology. Journal of the American College of Cardiology. 2015; 66(21): 2343 - 9.

150. Pizarro R, Bazzino OO, Oberti PF, Falconi ML, Arias AM, Krauss JG, et al. Prospective validation of the prognostic usefulness of B-type natriuretic peptide in asymptomatic patients with chronic severe aortic regurgitation. Journal of the American College of Cardiology. 2011; 58(16): 1705 - 14.

151. Рыбка М.М., Хинчагов Д.Я. Протоколы анестезиологического обеспечения кардиохирургических операций, выполняемых при ишемической болезни сердца, патологии клапанного аппарата, нарушениях ритма, гипертрофической кардиомиопатии, аневризмах восходящего отдела и дуги аорты у пациентов различных возрастных групп. Москва: НЦССХ; 2015. 77 p.

152. Рыбка М.М., Хинчагов Д.Я., Мумладзе К.В., Никулкина Е.С. Протоколы анестезиологического обеспечения рентгенэндоваскулярных и диагностических процедур, выполняемых у кардиохирургических пациентов различных возрастных групп. Москва: НМИЦССХ; 2018. 73 p.

153. Landoni G, Lomivorotov VV, Nigro Neto C, Monaco F, Pasyuga VV, Bradic N, et al. Volatile anesthetics versus total intravenous anesthesia for cardiac surgery. New England Journal of Medicine. 2019; 380(13): 1214 - 25.

154. Lancellotti P, Pibarot P, Chambers J, Edvardsen T, Delgado V, Dulgheru R, et al. Recommendations for the imaging assessment of prosthetic heart valves: a report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular . European Heart Journal - Cardiovascular Imaging. 2016; 17(6): 589 - 90.

155. Theresa A McDonagh, Marco Metra, Marianna Adamo, Roy S Gardner, Andreas Baumbach, Michael , et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC, European Heart Journal, Volume 42, Issue 36, 21 September 2021, Pages 3599 - 3726, https://doi.org/10.1093/eurheartj/ehab368

156. Пугина М.Ю., Гареев Д.А., Коржова М.А., et al. Патоморфологические особенности осложнений у пациентов с бикуспидальным аортальным клапаном. Южно-Российский журнал терапевтической практики. 2023; 4(3): 62 - 69

157. Irtyuga O, Kopanitsa G, Kostareva A, et al. Application of Machine Learning Methods to Analyze Occurrence and Clinical Features of Ascending Aortic Dilatation in Patients with and without Bicuspid Aortic Valve. J Pers Med. 2022; 12(5): 794. doi: 10.3390/jpm12050794

158. Дроздов Д.В., Макаров Л.М., Баркан В.С., и др. Регистрация электрокардиограммы покоя в 12 общепринятых отведениях взрослым и детям 2023. Методические рекомендации. Российский кардиологический журнал. 2023; 28(10): 5631. doi: 10.15829/1560-4071-2023-5631

159. Мацкеплишвили С.Т., Саидова М.А., Мироненко М.Ю., и др. Выполнение стандартной трансторакальной эхокардиографии. Методические рекомендации 2024. Российский кардиологический журнал. 2025; 30(2): 6271. https://doi.org/10.15829/1560-4071-2025-6271.

160. Демин А.А., Кобалава Ж.Д., Скопин И.И., и др. Инфекционный эндокардит и инфекция внутрисердечных устройств. Клинические рекомендации 2021. Российский кардиологический журнал. 2022; 27(10): 5233. https://doi.org/10.15829/1560-4071-2022-5233

161. Кобалава Ж.Д., Конради А.О., Недогода С.В., и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2024. Российский кардиологический журнал. 2024; 29(9): 6117. https://doi.org/10.15829/1560-4071-2024-6117.

162. Ежов М.В., Кухарчук В.В., Сергиенко И.В., и др. Нарушения липидного обмена. Клинические рекомендации 2023. Российский кардиологический журнал. 2023; 28(5): 5471. https://doi.org/10.15829/1560-4071-2023-5471

163. Skovbo Kristensen, Joachim S et al. "Exploring Drug Re-Purposing for Treatment of Abdominal Aortic Aneurysms: a Systematic Review and Meta-analysis." European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery vol. 67,4 (2024): 570 - 582. doi: 10.1016/j.ejvs.2023.11.037

164. Mazzolai, Lucia et al. "2024 ESC Guidelines for the management of peripheral arterial and aortic diseases." European heart journal vol. 45,36 (2024): 3538-3700. doi: 10.1093/eurheartj/ehae179

165. Галявич А.С., Терещенко С.Н., Ускач Т.М., и др. Хроническая сердечная недостаточность. Клинические рекомендации 2024. Российский кардиологический журнал. 2024; 29(11): 6162. https://doi.org/10.15829/1560-4071-2024-6162.

166. Gibson, C Michael et al. "Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI." The New England journal of medicine vol. 375,25 (2016): 2423-2434. doi: 10.1056/NEJMoa1611594

167. Pocar, Marco et al. "Predictors of adverse events after surgical ventricular restoration for advanced ischaemic cardiomyopathy." European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery vol. 37,5 (2010): 1093 - 100. doi: 10.1016/j.ejcts.2009.12.006.

168. Gropper MA, Miller RD, Eriksson LI, Fleisher LA, Wiener-Kronish JP, Cohen LH, et al. (7 October 2019). Miller's Anesthesia (9th ed.). Philadelphia, PA: Elsevier. ISBN 978-0-323-61264-7.

169. , Ahmet et al. "Vaccination of adults with heart failure and chronic heart conditions: Expert opinion." Turk Kardiyoloji Dernegi arsivi: Turk Kardiyoloji Derneginin yayin organidir vol. 46,8 (2018): 723-734. doi: 10.5543/tkda.2018.10.5543/tkda.2018.37048

170. Аверков О.В., Арутюнян Г.К., Дупляков Д.В., и др. Острый инфаркт миокарда с подъемом сегмента ST электрокардиограммы. Клинические рекомендации 2024. Российский кардиологический журнал. 2025; 30(3): 6306. https://doi.org/10.15829/1560-4071-2025-6306.

171. Барбараш О.Л., Карпов Ю.А., Панов А.В., и др. Стабильная ишемическая болезнь сердца. Клинические рекомендации 2024. Российский кардиологический журнал. 2024; 29(9): 6110. https://doi.org/10.15829/1560-4071-2024-6110.

172. Praz, F., Borger, M. A., Lanz, J., et al. ESC/EACTS Scientific Document Group (2025). 2025 ESC/EACTS Guidelines for the management of valvular heart disease. European heart journal, ehaf194. Advance online publication. https://doi.org/10.1093/eurheartj/ehaf194

173. Gatti M, Gallone G, Poggi V, Bruno F, Serafini A, Depaoli A, et al. Diagnostic accuracy of coronary computed tomography angiography for the evaluation of obstructive coronary artery disease in patients referred for transcatheter aortic valve implantation: a sys tematic review and meta-analysis. Eur Radiol 2022; 32: 5189 - 200. https://doi.org/10.1007/s00330-022-08603-y

174. Diller GP, Gerwing M, Boroni Grazioli S, De-Torres-Alba F, Radke RM, Vormbrock J, et al. Utility of coronary computed tomography angiography in patients undergoing transcatheter aortic valve implantation: a meta-analysis and meta-regression based on published data from 7458 pa-tients. J Clin Med 2024; 13: 631. https://doi.org/10. 3390/jcm13020631

175. Kondoleon NP, Layoun H, Spilias N, Sipko J, Kanaan C, Harb S, et al. Effectiveness of pre-TAVR CTA as a screening tool for significant CAD before TAVR. JACC Cardiovasc Interv 2023; 16: 1990 - 2000. https://doi.org/10.1016/j.jcin.2023.05.030

176. Chieffo A, Giustino G, Spagnolo P, Panoulas VF, Montorfano M, Latib A, et al. Routine screening of coronary artery disease with computed tomographic coronary angiography in place of invasive coronary angiography in patients undergoing transcatheter aortic valve replacement. Circ Cardiovasc Interv 2015; 8: e002025. https://doi.org/10.1161/circinterventions.114.002025

177. Иртюга О.Б., Ляпина И.Н., Воробьева Н.А., и др. Ключевые аспекты организации работы школы для пациентов, принимающих антагонисты витамина К. Согласованное мнение экс-пертов Российский кардиологический журнал 2025; 30(9): 6529. doi: 10.15829/1560-4071-2025-6529 ISSN 1560-4071

178. Brouwer J, Nijenhuis VJ, Delewi R, Hermanides RS, Holvoet W, Dubois CLF, et al. Aspirin with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med 2020; 383: 1447 - 57. https://doi.org/10.1056/NEJMoa2017815

179. Jiang, Yefan et al. "Mechanical versus Bioprosthetic Aortic Valve Replacement in Middle-Aged Adults: A Systematic Review and Meta-Analysis." Journal of cardiovascular development and disease vol. 10,2 90. 20 Feb. 2023, doi: 10.3390/jcdd10020090

180. Tasoudis, Panagiotis T et al. "Mechanical versus bioprosthetic valve for aortic valve replace-ment: systematic review and meta-analysis of reconstructed individual participant data." European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery vol. 62,1 (2022): ezac268. doi: 10.1093/ejcts/ezac268

181. Leviner, Dror B et al. "Mechanical vs Bioprosthetic Aortic Valve Replacement in Patients Younger Than 70 Years of Age: A Hazard Ratio Meta-analysis." The Canadian journal of cardiolo-gy vol. 38,3 (2022): 355 - 364. doi: 10.1016/j.cjca.2021.12.008

182. Engelen ET, Schutgens RE, Mauser-Bunschoten EP, van Es RJJ, van Galen KPM. Antifibrino-lytic therapy for preventing oral bleeding in people on anticoagulants under going minor oral sur-gery or dental extractions. Cochrane Database Syst Rev 2018; 7: CD012293. https://doi.org/10.1002/14651858.CD012293.pub2

183. Makuloluwa AK, Tiew S, Briggs M. Peri-operative management of ophthalmic patients on an-ti-thrombotic agents: a literature review. Eye (Lond) 2019; 33: 1044 - 59. https://doi.org/10.1038/s41433-019-0382-6

184. Nagata N, Yasunaga H, Matsui H, Fushimi K, Watanabe K, Akiyama J, et al. Therapeutic en-doscopy-related GI bleeding and thromboembolic events in patients using warfarin or direct oral anticoagulants: results from a large nationwide database analysis. Gut 2018; 67: 1805 - 12. https://doi.org/10.1136/gutjnl-2017-313999

185. Dohler I, Roder D, Schlesinger T, Nassen CA, Germer CT, Wiegering A, et al. Risk-adjusted perioperative bridging anticoagulation reduces bleeding complications without increasing thrombo-embolic events in general and visceral surgery. BMC Anesthesiol 2023; 23: 56. https://doi.org/10.1186/s12871-023-02017-z

186. Shah S, Nayfeh T, Hasan B, Urtecho M, Firwana M, Saadi S, et al. Perioperative man agement of vitamin K antagonists and direct oral anticoagulants: a systematic review and meta-analysis. Chest 2023; 163: 1245 - 57. https://doi.org/10.1016/j.chest.2022.11.032

187. Kovacs MJ, Wells PS, Anderson DR, Lazo-Langner A, Kearon C, Bates SM, et al. Postopera-tive low molecular weight heparin bridging treatment for patients at high risk of arterial thrombo-embolism (PERIOP2): double blind randomised controlled trial. BMJ 2021; 373: n1205. https://doi.org/10.1136/bmj.n1205

188. Kuo HC, Liu FL, Chen JT, Cherng YG, Tam KW, Tai YH. Thromboembolic and bleed ing risk of periprocedural bridging anticoagulation: a systematic review and meta-analysis. Clin Cardiol 2020;43:441-9. https://doi.org/10.1002/clc.23336

189. Mathias S., Nayak U.S., Isaacs B. Balance in elderly patients: the "get-up and go" test. Arch Phys Med Rehabil. 1986 Jun; 67(6): 387 - 9. PMID: 3487300.

190. Zigmond A.S., Snaith R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica. 1983; 67 (6): 361 - 370. doi:10.1111/j.16000447.1983.tb09716.x.

191. Borg G.A. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982; 14: 377 - 381.

192. Borg G.A. Psychophysical scaling with applications in physical work and the perception of exertion. ScandJWorkEnvironHealth. 1990; 16 (Suppl 1): 55 - 58.

193. Eleid MF, Nkomo VT, Pislaru SV, Gersh BJ. Valvular Heart Disease: New Concepts in Pathophysiology and Therapeutic Approaches. Annu Rev Med. 2023 Jan 27; 74: 155 - 170.

194. Tsurumi H, Kusunose K. Atrial fibrillation in chronic aortic regurgitation: the missing link in prognosis and surgical timing. Heart. 2025 Aug 11: heartjnl-2025-326727.

195. Zhang H, El-Am EA, Thaden JJ, Pislaru SV, Scott CG, Krittanawong C, Chahal AA, Breen TJ, Eleid MF, Melduni RM, Greason KL, McCully RB, Enriquez-Sarano M, Oh JK, Pellikka PA, Nkomo VT. Atrial fibrillation is not an independent predictor of outcome in patients with aortic stenosis. Heart. 2020 Feb; 106(4): 280 - 286.